SCHEMBL7965236

SCHEMBL7965236

c1ccc2c(c1)oc1cc(OC[C@@H]3CO3)ccc12

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.57
TP53 P04637 4/20 0.57
TSHR P16473 3/20 0.57
HIF1A Q16665 2/20 0.57
CYP3A4 P08684 1/20 0.57
SMN1; SMN2 Q16637 1/20 0.57
TDP1 Q9NUW8 1/20 0.54
MEN1 O00255 4/20 0.47
KMT2A Q03164 4/20 0.47
XDH P47989 4/20 0.46
LMNA P02545 2/20 0.46
NPC1 O15118 1/20 0.46
MAOA P21397 1/20 0.46
RAB9A P51151 1/20 0.46
FGFR1 P11362 1/20 0.45
SRC P12931 1/20 0.45
MAPT P10636 5/20 0.44
HPGD P15428 4/20 0.44
GAA P10253 2/20 0.44
CYP1A2 P05177 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7329771 0.92 MAOA (0.58) ALDH1A1TP53TSHRHIF1ACYP3A4
SCHEMBL8584061 0.84 ALDH1A1 (0.54) ALDH1A1TP53TSHRHIF1ACYP3A4
SCHEMBL10701911 0.83 ALDH1A1 (0.51) ALDH1A1TP53TSHRHIF1ACYP3A4
SCHEMBL8484884 0.82 ALDH1A1 (0.49) ALDH1A1TP53TSHRHIF1ACYP3A4
SCHEMBL8485841 0.79 MAOA (0.50) ALDH1A1TP53TSHRHIF1ACYP3A4
SCHEMBL10486553 0.78 TNKS (0.61) TP53CYP3A4SMN1; SMN2MEN1KMT2A
SCHEMBL7245118 0.76 NPC1 (0.51) ALDH1A1MEN1KMT2AXDHLMNA
SCHEMBL11096505 0.76 MAOB (0.63) ALDH1A1MAOARAB9AHPGDCYP1A2
SCHEMBL19183532 0.76 ALDH1A1 (0.62) ALDH1A1TP53TSHRSMN1; SMN2TDP1
SCHEMBL11030589 0.76 MAOA (0.62) MAOAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6242450-B1 SUBSTITUTED PIPERIDINES ELI LILLY AND COMPANY 2001-06-05 US disclosed
WO-2000006082-A2 TREATMENT OF ANXIETY DISORDERS ELI LILLY AND COMPANY (US) 2000-02-10 WO disclosed
WO-2000006166-A1 5-HT1F ANTAGONISTS ELI LILLY AND COMPANY (US) 2000-02-10 WO disclosed
EP-0976746-A1 5-HT1F antagonists ELI LILLY AND COMPANY (US) 2000-02-02 EP disclosed
EP-0976747-A2 Use of 5HT-1F receptor antagonists for treating anxiety disorders ELI LILLY AND COMPANY (US) 2000-02-02 EP disclosed